Goldblum Amiram Projects

Results Found (5)
Technology NameBriefcaseLead Researcher
Background Most active pharmaceutical ingredients (APIs) are not suitable for “passive” loading into nano-liposomes. The desired concentration in the nano-liposomes is hard to achieve. Consequently, the therapeutic efficacy in humans is not ...
More
Goldblum Amiram
COVID-19 Pepticom is implementing its proprietary core AI technology on various Coronavirus proteins and the ACE2 to identify novel inhibitors that can fight Sars Cov2. They are currently looking for partners to validate and develop these ...
More
Goldblum Amiram
 Background Toll-like receptors (TLRs) have been implicated in several autoimmune and inflammatory diseases, including cancer, diabetes, cardiovascular disease, atherosclerosis, Alzheimer’s disease, and chronic neuropathic pain. Currently, ...
More
Goldblum Amiram
  Categories Drug delivery, Infectious disease Development Stage Pre-clinical efficacy studies Patent Status Patent pending Market The invention is related to the field of antibiotic resistant bacteria (N. gonorrhoeae, MRSA, Streptococcus ...
More
Barenholz Yechezkel
Categories: Life sciences and Biotechnology Technology Keywords: Drug Development, PPARD, Obesity, Glycogen Preserving, Lipid Metabolism, Wound Healing Development Stage: In silico, Identification of lead molecules, in vitro ...
More
Goldblum Amiram